Medical Molecular Biology

Organisational unit: Research group

More filtering options
  1. 2018
  2. 2017
  3. 2016
  4. The Potential of MicroRNAs as Prostate Cancer Biomarkers.

    Fabris, L., Yvonne Ceder, Chinnaiyan, A. M., Jenster, G. W., Sorensen, K. D., Tomlins, S., Visakorpi, T. & Calin, G. A., 2016, In : European Urology. 70, 2, p. 312-322

    Research output: Contribution to journalReview article

  5. 2015
  6. Exosomal microRNAs as Potential Biomarkers in Castration-resistant Prostate Cancer.

    Haflidadottir, B. & Yvonne Ceder, 2015, In : European Urology. 67, 1, p. 42-43

    Research output: Contribution to journalDebate/Note/Editorial

  7. miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.

    Larne, O., Hagman, Z., Hans Lilja, Anders Bjartell, Edsjö, A. & Yvonne Ceder, 2015, In : Carcinogenesis. 36, 8, p. 858-866

    Research output: Contribution to journalArticle

  8. miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.

    Larne, O., Östling, P., Haflidadottir, B., Hagman, Z., Aakula, A., Kohonen, P., Kallioniemi, O., Edsjö, A., Anders Bjartell, Hans Lilja, Åke Lundwall & Yvonne Ceder, 2015, In : European Urology. 68, 4, p. 581-588

    Research output: Contribution to journalArticle

  9. 2013
  10. miQ - a novel microRNA based diagnostic and prognostic tool for prostate cancer.

    Larne, O., Martens-Uzunova, E., Hagman, Z., Edsjö, A., Lippolis, G., Vredenbregt-van den Berg, M. S., Anders Bjartell, Jenster, G. & Yvonne Ceder, 2013, In : International Journal of Cancer. 132, 12, p. 2867-2875

    Research output: Contribution to journalArticle

  11. miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.

    Hagman, Z., Haflidadottir, B., Jens Ceder, Larne, O., Anders Bjartell, Hans Lilja, Edsjö, A. & Yvonne Ceder, 2013, In : British Journal of Cancer. 108, 8, p. 1668-1676

    Research output: Contribution to journalArticle

  12. The tumour suppressor miR-34c targets MET in prostate cancer cells.

    Hagman, Z., Haflidadottir, B., Ansari, M., Persson, M., Anders Bjartell, Edsjö, A. & Yvonne Ceder, 2013, In : British Journal of Cancer. 109, 5, p. 1271-1278

    Research output: Contribution to journalArticle

  13. Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1.

    Haflidadottir, B., Larne, O., Myriam Martin, Persson, M., Edsjö, A., Anders Bjartell & Yvonne Ceder, 2013, In : PLoS ONE. 8, 8, e72400.

    Research output: Contribution to journalArticle

  14. 2011
  15. Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells.

    Ostling, P., Leivonen, S-K., Aakula, A., Kohonen, P., Mäkelä, R., Hagman, Z., Edsjö, A., Kangaspeska, S., Edgren, H., Nicorici, D., Anders Bjartell, Yvonne Ceder, Perälä, M. & Kallioniemi, O., 2011, In : Cancer Research. 71, p. 1956-1967

    Research output: Contribution to journalArticle

  16. 2010
  17. miR-34c is down regulated in prostate cancer and exerts tumor suppressive functions.

    Hagman, Z., Larne, O., Edsjö, A., Anders Bjartell, Ehrnström, R., David Ulmert, Hans Lilja & Yvonne Ceder, 2010, In : International Journal of Cancer. 127, 12, p. 2768-2776

    Research output: Contribution to journalArticle